A person being administered a shot of Covaxin during last year's clinical trials (PTI)
A person being administered a shot of Covaxin during last year's clinical trials (PTI)

Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine

The Indian embassy in Zimbabwe tweeted the announcement on Thursday. On March 3, Hyderabad-based Bharat Biotech International Limited, which has developed the shot, announced that it was 81% effective against coronavirus.
By hindustantimes.com | Written by Karan Manral
UPDATED ON MAR 04, 2021 06:31 PM IST

The Indian embassy in Zimbabwe announced on Thursday the African country has approved the made-in-India vaccine against the coronavirus disease (Covid-19), Covaxin, becoming the first country in the continent to approve the shot developed by Bharat Biotech International Limited.

“Zimbabwe has authorized use of COVAXIN, India’s indigenous COVID-19 vaccine, becoming the first country in Africa to do so. Trying to get it to Zimbabwe at an early date,” the embassy, located in Zimbabwe’s capital city of Harare, tweeted.


The development comes a day after Hyderabad-based Bharat Biotech announced that Covaxin has an efficacy rate of 81%, based on preliminary results from its phase 3 clinical trials. Covaxin, India’s first and so far the only homemade shot against the viral disease, found itself at the centre of a controversy in January, when it was one of the two vaccines cleared by the Drugs Controller General of India (DCGI) for the country’s vaccination drive, which began on January 16.

Also Read | Covaxin has 81% efficacy, says Bharat Biotech: What does it mean

It was alleged that Covaxin was given approval for use without the completion of its phase 3 trials. The other, Oxford University-AstraZeneca’s vaccine, was last year found to be more than 70% effective against the disease. Pune-based Serum Institute of India (SII) is manufacturing Oxford University-AstraZeneca vaccine as Covishield in the country.

Also Read | Concerns over Covaxin as some cite ‘lack of data’

On Monday, when the second phase of the vaccination drive commenced, Prime Minister Narendra Modi was administered his first dose of the Covid-19 vaccine. PM Modi chose to be administered a shot of Covaxin to clear the hesitancy surrounding it; second dose will be administered after 28 days.

Also Read | PM Narendra Modi gets Bharat Biotech’s Covaxin as India expands drive

Under its ‘Vaccine Maitri’ initiative, India has been sending consignments of vaccine doses to several countries. However, the doses being dispatched are of Covishield. Last month, Bharat Biotech had sought approval for Covaxin in more than 40 countries.

Also Read | Bharat Biotech seeks Covid-19 vaccine approval in over 40 countries

According to Johns Hopkins University, Zimbabwe, which has a population of more than 14 million, has recorded 36,179 Covid-19 cases thus far. The related death toll here stands at 1,478.

SHARE THIS ARTICLE ON

Related Stories

The Finance Minister's commitment "will help contain, and lead our nation towards accomplishing a Covid-19 disease free Bharat," said Bharat Biotech chairman and managing director Krishna Ella.(MINT_PRINT)
The Finance Minister's commitment "will help contain, and lead our nation towards accomplishing a Covid-19 disease free Bharat," said Bharat Biotech chairman and managing director Krishna Ella.(MINT_PRINT)

'People criticised us': Bharat Biotech head on Covaxin's journey from March 2020

By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON MAR 04, 2021 09:51 AM IST
If people have got patience, they should read those articles, Krishna Ella said.
The vaccine manufacturer declared on Wednesday that as per preliminary results of the phase 3 clinical trial Covaxin possess an efficacy of 81% .(Amal KS/ Hindustan Times)
The vaccine manufacturer declared on Wednesday that as per preliminary results of the phase 3 clinical trial Covaxin possess an efficacy of 81% .(Amal KS/ Hindustan Times)

Covaxin demonstrates prowess of Atmanirbhar Bharat, says ICMR chief

By hindustantimes.com | Edited by Ayshee Bhaduri
PUBLISHED ON MAR 03, 2021 08:01 PM IST
  • Bharat Biotech developed the country’s first indigenous vaccine, Covaxin, in partnership with ICMR.
Bharat Biotech has said efficacy data from a late-stage trial on nearly 26,000 volunteers who took Covaxin will be out soon. (ANI Photo)
Bharat Biotech has said efficacy data from a late-stage trial on nearly 26,000 volunteers who took Covaxin will be out soon. (ANI Photo)

Inspired, humbled: Bharat Biotech tweets after PM Modi takes Covaxin

By hindustantimes.com | Written by Meenakshi Ray
PUBLISHED ON MAR 01, 2021 02:25 PM IST
PM Modi took his first dose of Covaxin at Delhi’s All India Institute of Medical Science (AIIMS) and urged those who are eligible to get inoculated.
Harsh Vardhan said that he would do the booking of the vaccine today and plans to get vaccinated tomorrow.
Harsh Vardhan said that he would do the booking of the vaccine today and plans to get vaccinated tomorrow.

'PM Modi gave a clear message to nation by taking Covaxin': Harsh Vardhan

By Susmita Pakrasi
UPDATED ON MAR 01, 2021 02:24 PM IST
  • PM Modi, earlier in the day, took his first dose of the Covid-19 vaccine at AIIMS and appealed to all those who are eligible to get inoculated.
"There is a strong interest in Covaxin from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently," Bharat Biotech said.(Bloomberg)
"There is a strong interest in Covaxin from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently," Bharat Biotech said.(Bloomberg)

Bharat Biotech confirms deal with Brazil for 20 million doses of Covaxin

ANI |
PUBLISHED ON FEB 26, 2021 08:45 PM IST
"The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus," Bharat Biotech said in a statement.
Close
SHARE
Story Saved
OPEN APP